FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like 3 Rock-Bottom Biotechs That Big Market Players are Betting On May 15, 2017 Despite Recent Layoffs, Eli Lilly to Invest $850 Million in U.S. Operations March 23, 2017 U.S. Department of Justice to Take on Opioid Manufacturers and Distributors February 28, 2018
